In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus

V Combes1, A C Simon, G E Grau

  • 1Laboratory of Hematology and Immunology, UPRES EA 2195, UFR de Pharmacie, 13385 Marseille, France.

Insights

Endothelial microparticles (EMPs) from TNF-stimulated cells are procoagulant and adhesive. These EMPs are detectable in healthy individuals and increased in patients with coagulation disorders, suggesting a role in thrombotic conditions.

Area of Science:

  • Vascular Biology
  • Hematology
  • Cell Biology

Background:

  • Microparticles (MPs) from platelets and blood cells are known, but endothelial-derived MPs (EMPs) are less understood.
  • Vascular diseases are associated with increased MPs, yet the specific role of EMPs remains unclear.

Purpose of the Study:

  • To characterize the morphological, immunological, and functional properties of EMPs.
  • To determine if EMPs are detectable in humans and elevated in prothrombotic conditions.

Main Methods:

  • Human umbilical vein endothelial cells (HUVECs) were stimulated with TNF to induce EMP release.
  • Electron microscopy, immunophenotyping (e.g., alphavbeta3), and coagulation assays were performed.
  • EMPs were quantified in healthy individuals and patients with coagulation abnormalities.

Main Results:

  • TNF stimulation increased EMP release from HUVECs, characterized by bleb formation.
  • EMPs expressed cell surface antigens and demonstrated procoagulant activity via a tissue factor/factor VII pathway.
  • EMPs showed adhesion potential (E-selectin, ICAM-1, alphavbeta3, PECAM-1) and were detected in normal blood, elevated in patients with lupus anticoagulant.

Conclusions:

  • Endothelial microparticles can be induced by TNF and possess both procoagulant and adhesive properties.
  • EMPs are detectable in human circulation and may contribute to the pathogenesis of thrombotic disorders.
  • EMPs may serve as biomarkers for thrombotic conditions, particularly those involving coagulation abnormalities.